Login
← Go Back
Senores Pharmaceuticals
SENORES · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 30, 2024
Stock Price vs Company Growth
1d
2.9%
1w
2.9%
1m
2.4%
3m
5.9%
6m
21.7%
1y
49.6%
all
42.4%
đŸ¤” How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 813 2.9%
740
876
Company Overview
Sales
589 Cr
Growth: 40.3%
Profit after Tax
102 Cr
Growth: 16.6%
Small Cap
3,744 Cr
P/E: 36.7x
Industry P/E: 30.0x
Fundamentals
Sales (Cr) ₹ 589
Growth 40.3%
EBITDA 26.7%
P/S 6.4x
Dividend 0.0%
P/E 36.7x
Book Value ₹ 189
PEG Ratio 0.9x
ROE 12.3%
P/B 4.3x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
Senores Pharmaceuticals Limited was originally incorporated as ‘Senores Pharmaceuticals Private Limited’ under the Companies Act, 2013 through certificate of incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Belongs to (4 Indices)
Investors (10)
jeshika....
sanjay.s...
pratik.s...
Followers (1)
varsha96